Status:
NOT_YET_RECRUITING
Personalized Follow-up Program in the Type 2 Diabetes Prevention
Lead Sponsor:
GCS Ramsay Santé pour l'Enseignement et la Recherche
Conditions:
Type2 Diabetes
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
In France, the global prevalence of diabetes was estimated to 5% of the population in 2016, the type two diabetes (DT2) corresponding to 90% of cases. This number is widely underestimated because most...
Detailed Description
This study includes a personalized care program, including the patient follow-up by a nurse during 5 years with a contact every 4 months for the first year, then after every 6 months. The nurse will r...
Eligibility Criteria
Inclusion
- Person with a FINDRISC score ≥ 10 points
- Person who has given his/her express written and informed consent
Exclusion
- \- Person already diagnosed with a type 2 diabetes
Key Trial Info
Start Date :
October 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 10 2026
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT04907760
Start Date
October 10 2021
End Date
October 10 2026
Last Update
September 16 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.